KAT2A and melanoma: The Chromatin Immunoprecipitation (ChIP)-seq and Assay for Transposase-Accessible Chromatin with high-throughput Sequencing (ATAC-seq) analysis of KAT2A are warranted to be performed in the future to thoroughly determine the epigenetic roles of KAT2A in melanoma.